HD-OPM Archive
Topics › Statins

PREVENTABLE: 20,000-person trial of atorvastatin 40 mg to prevent dementia over age 75

Louis Nervegna · Jun 23, 2025 · ♥ 16 reactions · 5 comments · original Facebook post
StatinsBrain health & dementia
AI summary & key facts

Louis describes the ongoing PREVENTABLE trial, which randomizes about 20,000 community-dwelling adults aged 75+ to atorvastatin 40 mg or placebo to test whether statins prevent dementia. Atorvastatin was chosen because it is lipophilic and crosses the blood-brain barrier; the trial began in 2020 and is still recruiting.

The PREVENTABLE trial is a huge 20,000 person multicenter randomized controlled trial that aims to definitively answer the question:

Can statins prevent Alzheimer’s and other forms of dementia in healthy people over 75yo?

————-

The study began in 2020, and is still actively recruiting.

The intervention group will receive 40mg generic atorvastatin.

The control group will receive an identical placebo.

(The researchers purposely chose atorvastatin for this study because it is lipophilic and easily crosses the blood brain barrier.)

The full listing for the trial on clinicaltrials dot gov can be found here:

clinicaltrials.govClinicalTrials.govclinicaltrials.gov

The webpage for the trial is here:

preventabletrial.orgPREVENTABLEpreventabletrial.org

As we’ve spoken about many times in the group, there is a large amount of observational research that associates statin use with lower rates of Alzheimer’s. You can view some of those posts by clicking on the tag #statinsdementiaHD.

There is also a lot of mechanistic data that suggests the pathogenesis of Alzheimer’s involves over-activation of the mevalonate pathway in the brain, which statins target. This is the same pathway by which cells synthesize cholesterol, among other things.

So a large trial like this in humans is long overdue.

This trial will finally answer the question of whether or not statins can prevent dementia.

Quoted from the clinical trials dot gov website:

“PREVENTABLE will randomly assign atorvastatin 40 mg daily or matching placebo daily to approximately 20,000 community-dwelling adults 75 years of age or older without clinically evident cardiovascular disease, significant disability, or dementia, and follow them for up to 5 years (estimated median of 3.8 years). The study will enroll participants from approximately 100 US sites.”

“Primary Outcome Measures: Number of patients without diagnosis of new dementia in each group (placebo vs. atorvastatin)
Time frame: 4 years”

#statinsHD #alzheimersHD #dementiaHD #statinsdementiaHD #ldldementiaHD #preventableHD #atorvastatinHD #statinselderlyHD

Research cited

Healthy aging is important to all of us. The #PREVENTABLEtrial is enrolling adults 75+ to learn more about preventing dementia for future generations. Visit preventablecommunity.org to learn more about the study.

No photo description available.
← newer: Two RCTs found statins neither helped nor harmed Alzheimer'solder: UK Biobank: 3 cups of coffee a day linked to 48% lower cardi →